PNT

POINT Biopharma Global Inc. Common Stock

Delisted

PNT was delisted on the 26th of December, 2023.

130 hedge funds and large institutions have $571M invested in POINT Biopharma Global Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 49 increasing their positions, 32 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
130
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$70K
Puts
$679K
Net Calls
Net Calls Change

Top Buyers

1 +$11.4M
2 +$8.71M
3 +$7.85M
4
Nuveen Asset Management
Nuveen Asset Management
Illinois
+$6.08M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$5.27M

Top Sellers

1 -$22.2M
2 -$17.3M
3 -$10.7M
4
APM
Avidity Partners Management
Texas
-$6.7M
5
Citadel Advisors
Citadel Advisors
Florida
-$6.64M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$1.18M
52
$1.05M
53
$1.04M
54
$1.03M
55
$920K
56
$915K
57
$899K
58
$860K
59
$849K
60
$778K
61
$742K
62
$726K
63
$674K
64
$643K
65
$634K
66
$580K
67
$572K
68
$569K
69
$563K
70
$541K
71
$518K
72
$516K
73
$506K
74
$478K
75
$453K